RN193 is a type II kinase inhibitor with a human PAK1 IC 50 of 4.28 μM. RN193 functionally inhibits kinase activity of PAK1 , PAK2 , and PAK3 , and engages with their kinase domains in live cells. RN193 induces thermal shifts in CLK1 , GSK3B , ULK1 , MELK , MAPK13 , BRAF , and STK10 , indicating binding and stabilization of these proteins. RN193 induces formation of PAK3 : PAK2 heterodimers and displaces PAK2 homodimers in live cells. RN193 acts as a tool compound for studying group I PAK conformational states.
Products | Products > Disease Areas > Others | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Others | Products > Signaling Pathways > PAK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.